171 related articles for article (PubMed ID: 23814464)
1. Influence of anatomic location of lidocaine patch 5% on effectiveness and tolerability for postherpetic neuralgia.
Nalamachu S; Wieman M; Bednarek L; Chitra S
Patient Prefer Adherence; 2013; 7():551-7. PubMed ID: 23814464
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of lidocaine patch 5% to treat herpes zoster acute neuralgia and to prevent postherpetic neuralgia.
Bianchi L; Piergiovanni C; Marietti R; Renzini M; Gori F; Hansel K; Tramontana M; Stingeni L
Dermatol Ther; 2021 Jan; 34(1):e14590. PubMed ID: 33244838
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing and managing postherpetic neuralgia.
Nalamachu S; Morley-Forster P
Drugs Aging; 2012 Nov; 29(11):863-9. PubMed ID: 23038608
[TBL] [Abstract][Full Text] [Related]
4. Topical lidocaine for the treatment of postherpetic neuralgia.
Khaliq W; Alam S; Puri N
Cochrane Database Syst Rev; 2007 Apr; (2):CD004846. PubMed ID: 17443559
[TBL] [Abstract][Full Text] [Related]
5. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial.
Katz NP; Gammaitoni AR; Davis MW; Dworkin RH;
Pain Med; 2002 Dec; 3(4):324-32. PubMed ID: 15099237
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
[TBL] [Abstract][Full Text] [Related]
7. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia.
Davies PS; Galer BS
Drugs; 2004; 64(9):937-47. PubMed ID: 15101784
[TBL] [Abstract][Full Text] [Related]
8. Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain.
White WT; Patel N; Drass M; Nalamachu S
Pain Med; 2003 Dec; 4(4):321-30. PubMed ID: 14750908
[TBL] [Abstract][Full Text] [Related]
9. Lidocaine 700 mg medicated plaster for postherpetic neuralgia: real-world data from the German Pain e-Registry.
Überall MA; Eerdekens M; Hollanders E; Bösl I; Sabatschus I
Pain Manag; 2022 Mar; 12(2):195-209. PubMed ID: 34372662
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.
Hans G; Sabatowski R; Binder A; Boesl I; Rogers P; Baron R
Curr Med Res Opin; 2009 May; 25(5):1295-305. PubMed ID: 19366301
[TBL] [Abstract][Full Text] [Related]
11. Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology.
Mallick-Searle T; Snodgrass B; Brant JM
J Multidiscip Healthc; 2016; 9():447-454. PubMed ID: 27703368
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of piroxicam patch compared to lidocaine patch for the treatment of postherpetic neuralgia.
Kim JY; Lim HJ; Lee WJ; Lee SJ; Kim DW; Kim BS
Ann Dermatol; 2011 May; 23(2):162-9. PubMed ID: 21747614
[TBL] [Abstract][Full Text] [Related]
13. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.
Galer BS; Rowbotham MC; Perander J; Friedman E
Pain; 1999 Apr; 80(3):533-538. PubMed ID: 10342414
[TBL] [Abstract][Full Text] [Related]
14. Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: a double-blind and vehicle-controlled study.
Lin PL; Fan SZ; Huang CH; Huang HH; Tsai MC; Lin CJ; Sun WZ
Reg Anesth Pain Med; 2008; 33(4):320-5. PubMed ID: 18675742
[TBL] [Abstract][Full Text] [Related]
15. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.
Webster LR; Tark M; Rauck R; Tobias JK; Vanhove GF
BMC Neurol; 2010 Oct; 10():92. PubMed ID: 20937130
[TBL] [Abstract][Full Text] [Related]
16. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
[TBL] [Abstract][Full Text] [Related]
17. Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report.
Sayanlar J; Guleyupoglu N; Portenoy R; Ashina S
J Headache Pain; 2012 Oct; 13(7):587-9. PubMed ID: 22717586
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
Armstrong EP; Malone DC; McCarberg B; Panarites CJ; Pham SV
Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358
[TBL] [Abstract][Full Text] [Related]
20. Lidocaine patch 5%.
Comer AM; Lamb HM
Drugs; 2000 Feb; 59(2):245-9; discussion 250-1. PubMed ID: 10730547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]